Local reactions, consisting mostly of mild or moderate pain, were least frequent with monovalent HA. Antibody concentrations to both antigens were similar in groups A and B, in which HA ...

Antibodies are secreted immunoglobulin molecules ... to aggravate inflammation and colitis in mouse models. Influenza A HA plasticity often leads to resistant strains that compromise mAb potency ...

FUJIFILM Healthcare Americas Corporation, a leading provider of endoscopic imaging and endosurgical solutions, will showcase its industry leading endoscopic imaging technology portfolio, including two ...

Ceragon , a leading solutions provider of end-to-end wireless connectivity, today announced that its management will participate in the 20th Annual Needham Technology, Media, & Consumer 1x1 Conference ...

A Wisconsin man has been bitten by snakes hundreds of times, and scientists are studying his blood to treat snakebite.

- PLT012 has received FDA Orphan Drug Designation for liver and intrahepatic bile duct cancers with IND submission expected by end of 2025 EPALINGES, Switzerland, April 29, 2025--(BUSINESS WIRE ...

Hepatocellular carcinoma (HCC) is a common malignant tumor and the third leading cause of cancer-related mortality. The lack ...

The paper, titled: "PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Anti-Tumor Immunity Against Liver Cancer and Liver Metastasis," establishes PLT012 as the first ...

Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism, ...

The potential of monoclonal antibodies (mAbs) as therapies is indisputable. The current mAbs market is expected to be around ~USD 150 billion. In 2021, five out of the top 10 selling drugs were ...

(NEPC). The findings enhance the understanding of the treatment of androgen receptor functions in NEPC. Neuroendocrine prostate cancer (NEPC) arises primarily through neuroendocrine ...